Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PRF TechnologiesPRFX -2.38%22 PB Ratio is 0.18 as of Sep. 09, 2026, which is 10% below its 10-year median of 0.20. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 918 Drug Manufacturers companies, PRF Technologies ranks better than 98.91% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-09), PRF Technologies's share price is $0.9324. PRF Technologies's Book Value per Share for the quarter that ended in Jun. 2026 was $5.22. Hence, PRF Technologies's PB Ratio of today is 0.18.
The historical rank and industry rank for PRF Technologies's PB Ratio or its related term are showing as below:
PRFX'
s PB Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.2 Max: 0.55
Current: 0.18
During the past 8 years, PRF Technologies's highest PB Ratio was 0.55. The lowest was 0.09. And the median was 0.20.
PRFX's PB Ratio is ranked better than 98.91% of 918
companies
in the Drug Manufacturers industry
Industry Median: 1.98
vs PRFX: 0.18
During the past 12 months, PRF Technologies's average Book Value Per Share Growth Rate was -75.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -79.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -72.70% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of PRF Technologies was -39.80% per year. The lowest was -85.40% per year. And the median was -79.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PRF Technologies PB Ratio Related Terms
PRF Technologies PB Ratio Historical Data
* Premium members only.
The historical data trend for PRF Technologies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PRF Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRF Technologies PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PRF Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where PRF Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PRF Technologies (PRFX) has a PB Ratio of 0.18 as of Sep. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PRF Technologies and its competitors. This is 10% below median its historical median of 0.20. Over the past decade, PRF Technologies' PB Ratio has ranged from 0.09 to 0.55. According to the industry distribution chart, PRF Technologies ranks #10 out of 918 companies in the Drug Manufacturers industry, placing it in the top 1.1%.
Is PRF Technologies' PB Ratio too high?
PRF Technologies' current PB Ratio of 0.18 is 10% below median its 10-year median of 0.20. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.55. The Drug Manufacturers industry median PB Ratio is 1.98. PRF Technologies' value of 0.18 is 90.9% below this industry median. Based on the distribution chart, PRF Technologies ranks #10 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' PB Ratio compare to CTTH and UPC?
According to the Drug Manufacturers industry distribution chart, PRF Technologies ranks #10 out of 918 companies for PB Ratio. This places PRF Technologies in the top 1% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. PRF Technologies' value of 0.18 is 90.9% below this benchmark. Historically, PRF Technologies' own PB Ratio has ranged from 0.09 to 0.55 over the past decade. While the company's 10-year median is 0.20 vs. the industry median of 1.98, PRF Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.98, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PRF Technologies's current PB Ratio of 0.18 is 90.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PRF Technologies and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PRF Technologies's current PB Ratio is 0.18, which is 10% below median its own 10-year median of 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current PB Ratio of 0.18. The current PB Ratio is 0.18, which is 10% below median its 10-year median of 0.20 and 90.9% below the Drug Manufacturers industry median of 1.98. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PRF Technologies (PRFX), the current PB Ratio is 0.18 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score
Get the complete analysis for PRFX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRFX has been successfully added to your 
